Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-low Induction of Therapy Resistance.
Cotter KA, Gallon J, Uebersax N, Rubin P, Meyer KD, Piscuoglio S, Jaffrey SR, Rubin MA
Mol Cancer Res. 2021 Jun 4. pii: 1541-7786.MCR-21-0014. doi: 10.1158/1541-7786.MCR-21-0014.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 162984 | METTL3 shRNA 2 tet pLKO puro | Tet-inducible shRNA targeting human METTL3 #2 |
| 162985 | METTL3 shRNA 1 tet pLKO puro | Tet-inducible shRNA targeting human METTL3 #1 |
| 163017 | GFP shRNA tet pLKO puro | Control tet-inducible shRNA targeting eGFP |